Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M209,882Revenue (TTM) $M52,759Net Margin (%)17.5Altman Z-Score3.5
Enterprise Value $M230,722EPS (TTM) $1.4Operating Margin %27.5Piotroski F-Score5
P/E(ttm)23.0Beneish M-Score-2.9Pre-tax Margin (%)24.0Higher ROA y-yN
Price/Book11.210-y EBITDA Growth Rate %1.8Quick Ratio0.8Cash flow > EarningsY
Price/Sales4.15-y EBITDA Growth Rate %1.2Current Ratio1.1Lower Leverage y-yY
Price/Free Cash Flow18.7y-y EBITDA Growth Rate %1.3ROA % (ttm)12.4Higher Current Ratio y-yN
Dividend Yield %3.3PEG19.6ROE % (ttm)48.2Less Shares Outstanding y-yY
Payout Ratio %77.0Shares Outstanding M6,818ROIC % (ttm)30.1Gross Margin Increase y-yN

Gurus Latest Trades with RHHBY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RHHBYKen Fisher 2016-06-30 Add0.01%$30.26 - $33.68
($31.82)
$ 30.79-3%Add 1.58%15,142,209
RHHBYKen Fisher 2016-03-31 Add0.02%$30.09 - $34.47
($31.91)
$ 30.79-4%Add 1.88%14,906,191
RHHBYKen Fisher 2015-12-31 Add0.01%$32.55 - $35.08
($33.69)
$ 30.79-9%Add 0.63%14,630,453
RHHBYKen Fisher 2015-09-30 Add0.02%$31.65 - $36.87
($34.69)
$ 30.79-11%Add 2.30%14,538,602
RHHBYKen Fisher 2015-06-30 Add0.8%$34.38 - $38.46
($36.09)
$ 30.79-15%Add 409.71%14,211,412
RHHBYKen Fisher 2015-03-31 Reduce$32.1 - $36.505
($34.06)
$ 30.79-10%Reduce -1.24%2,788,126
RHHBYKen Fisher 2014-12-31 Add0.07%$34.16 - $37.92
($36.33)
$ 30.79-15%Add 49.26%2,823,025
RHHBYKen Fisher 2014-06-30 Reduce-0.07%$35.42 - $38.07
($36.82)
$ 30.79-16%Reduce -49.71%1,813,443
RHHBYKen Fisher 2014-03-31 Add0.07%$18.14 - $38.17
($29.75)
$ 30.793%Add 99.00%1,803,070
RHHBYKen Fisher 2013-12-31 Reduce$31.96 - $35.24
($34.15)
$ 30.79-10%Reduce -0.26%1,812,112
RHHBYKen Fisher 2013-09-30 Add$30.66 - $33.77
($31.86)
$ 30.79-3%Add 0.28%1,816,868
RHHBYTweedy Browne 2013-06-30 Sold Out $28.92 - $32.98
($30.92)
$ 30.79-0%Sold Out0
RHHBYKen Fisher 2013-06-30 Add$28.92 - $32.98
($30.92)
$ 30.79-0%Add 0.90%1,811,804
RHHBYKen Fisher 2013-03-31 Add0.12%$25.62 - $29.3
($27.78)
$ 30.7911%Add 634.57%1,795,722
RHHBYTweedy Browne 2012-12-31 Reduce$23.08 - $25.68
($24.54)
$ 30.7925%Reduce -3.04%120,548
RHHBYKen Fisher 2012-12-31 Reduce$23.08 - $25.68
($24.54)
$ 30.7925%Reduce -14.81%244,460
RHHBYTweedy Browne 2012-09-30 Reduce-0.03%$20.99 - $24.07
($22.5)
$ 30.7937%Reduce -24.31%124,328
RHHBYKen Fisher 2012-09-30 Reduce$20.99 - $24.07
($22.5)
$ 30.7937%Reduce -7.27%286,946
RHHBYVanguard Health Care Fund 2012-06-30 Add2.96%$19.43 - $23.14
($21.18)
$ 30.7945%Add 543.36%8,547,954
RHHBYKen Fisher 2012-06-30 Reduce-0.01%$19.43 - $23.14
($21.18)
$ 30.7945%Reduce -24.26%309,426
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RHHBY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


RHHBY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about RHHBY:

    News about RHHBY:

    Articles On GuruFocus.com
    Can Novartis Tide Over the Alcon Crisis? Aug 26 2016 
    Innovative Diagnostic and Therapeutic Products Seen at Roche Aug 22 2016 
    Siegfried Holdings, Held by Tweedy Browne, Way Undervalued Jul 22 2016 
    Roche Holdings Definitely Not a Lumbering Giant Jul 11 2016 
    Invesco Adds to Holdings in Investment, Financial Services Companies Jul 01 2016 
    Bearish Sentiment in Becton Dickinson's Stock Apr 27 2016 
    Does Biotech’s Recent Bounce Have Legs? Apr 22 2016 
    Invesco European Growth Fund Adds to More Than 40 Existing Stakes Apr 04 2016 
    Invesco European Growth Fund Adds to 7 Stakes Jan 26 2016 
    Ken Fisher Cuts His Stake in Royal Bank, Buys Roche Holding Oct 12 2015 

    More From Other Websites
    New Zika Screening Rule Could Boost Hologic Sales Growth Aug 26 2016
    Why Roche Might Be Interested in BioMarin Aug 25 2016
    Medivation: The Latest Analyst Recommendations Aug 24 2016
    Roche Launches Accu-Chek Blood Glucose Monitoring System Aug 23 2016
    Innovative Diagnostic and Therapeutic Products Seen at Roche Aug 22 2016
    ROCHE HOLDING LTD /FI Financials Aug 16 2016
    Movers and Shakers in Biotech: Global Blood Therapeutics Inc (GBT) and Eleven Biotherapeutics Inc... Aug 15 2016
    How Did Valeant’s Segments Perform in 2Q16? Aug 12 2016
    Biogen Stock Pops As Merck, Allergan Reportedly Probing Buyout Aug 02 2016
    Roche launches new target enrichment systems for genetic and translational research Aug 02 2016
    Roche introduces virtual reality theater at AACC 2016 Clinical Lab Expo to give lab professionals... Aug 02 2016
    Roche receives CLIA waiver for cobas® Influenza A/B & RSV test for the cobas® Liat® Aug 01 2016
    Make Drugmakers Pay: England’s Strategy for Cancer Medicines Jul 28 2016
    Analyst Recommendations for Roche: Buy, Hold, or Sell? Jul 27 2016
    Factors Contributing to Roche’s Core Operating Margin Jul 27 2016
    How Roche’s Diagnostics Division Performed in 1H16 Jul 26 2016
    A Look at Roche’s Potential Revenue Drivers Jul 26 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)